Pre-Clinical Trials

IRE for brain cancer using canine patients with spontaneous disease:

Canine patient 1 week post IRE

Canine patient 1 month post IRE

Spontaneous canine glioma models are exceptional clinical translation of IRE for brain tumor treatment:

– Canines develop spontaneous gliomas 3X more often than people

– Large animal studies allow for testing of clinical size probes

– Pathophysiology of spontaneous tumors are analogous to brain cancer in people

Preclinical models allow for evaluation of clinical safety and feasibility of irreversible electroporation implementation in the clinic.